PMC:7652766 / 28443-28838 JSONTXT

{"project":"LitCovid-PD-HP","denotations":[{"id":"T47","span":{"begin":25,"end":38},"obj":"Phenotype"},{"id":"T48","span":{"begin":52,"end":58},"obj":"Phenotype"},{"id":"T49","span":{"begin":183,"end":192},"obj":"Phenotype"},{"id":"T50","span":{"begin":199,"end":205},"obj":"Phenotype"},{"id":"T51","span":{"begin":210,"end":218},"obj":"Phenotype"}],"attributes":[{"id":"A47","pred":"hp_id","subj":"T47","obj":"http://purl.obolibrary.org/obo/HP_0000458"},{"id":"A48","pred":"hp_id","subj":"T48","obj":"http://purl.obolibrary.org/obo/HP_0001297"},{"id":"A49","pred":"hp_id","subj":"T49","obj":"http://purl.obolibrary.org/obo/HP_0002315"},{"id":"A50","pred":"hp_id","subj":"T50","obj":"http://purl.obolibrary.org/obo/HP_0002018"},{"id":"A51","pred":"hp_id","subj":"T51","obj":"http://purl.obolibrary.org/obo/HP_0002013"}],"text":") and specific symptoms (loss of smell or taste and stroke) were described (91, 113–115). Epidemiological studies have reported that some patients infected with SARS‐CoV‐2 did report headaches (8%), nausea, or vomiting (1%). A more recent study investigating 214 COVID‐19 patients found that about 88% of critically ill patients displayed neurologic manifestations, including acute cerebrovascul"}

{"project":"LitCovid-sentences","denotations":[{"id":"T147","span":{"begin":90,"end":224},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":") and specific symptoms (loss of smell or taste and stroke) were described (91, 113–115). Epidemiological studies have reported that some patients infected with SARS‐CoV‐2 did report headaches (8%), nausea, or vomiting (1%). A more recent study investigating 214 COVID‐19 patients found that about 88% of critically ill patients displayed neurologic manifestations, including acute cerebrovascul"}

{"project":"LitCovid-PubTator","denotations":[{"id":"1128","span":{"begin":138,"end":146},"obj":"Species"},{"id":"1129","span":{"begin":161,"end":171},"obj":"Species"},{"id":"1130","span":{"begin":272,"end":280},"obj":"Species"},{"id":"1131","span":{"begin":320,"end":328},"obj":"Species"},{"id":"1132","span":{"begin":225,"end":226},"obj":"Gene"},{"id":"1137","span":{"begin":52,"end":58},"obj":"Disease"},{"id":"1138","span":{"begin":147,"end":155},"obj":"Disease"},{"id":"1139","span":{"begin":183,"end":192},"obj":"Disease"},{"id":"1140","span":{"begin":199,"end":205},"obj":"Disease"},{"id":"1141","span":{"begin":210,"end":218},"obj":"Disease"},{"id":"1142","span":{"begin":263,"end":271},"obj":"Disease"},{"id":"1143","span":{"begin":305,"end":319},"obj":"Disease"}],"attributes":[{"id":"A1128","pred":"tao:has_database_id","subj":"1128","obj":"Tax:9606"},{"id":"A1129","pred":"tao:has_database_id","subj":"1129","obj":"Tax:2697049"},{"id":"A1130","pred":"tao:has_database_id","subj":"1130","obj":"Tax:9606"},{"id":"A1131","pred":"tao:has_database_id","subj":"1131","obj":"Tax:9606"},{"id":"A1132","pred":"tao:has_database_id","subj":"1132","obj":"Gene:351"},{"id":"A1137","pred":"tao:has_database_id","subj":"1137","obj":"MESH:D020521"},{"id":"A1138","pred":"tao:has_database_id","subj":"1138","obj":"MESH:D007239"},{"id":"A1139","pred":"tao:has_database_id","subj":"1139","obj":"MESH:D006261"},{"id":"A1140","pred":"tao:has_database_id","subj":"1140","obj":"MESH:D009325"},{"id":"A1141","pred":"tao:has_database_id","subj":"1141","obj":"MESH:D014839"},{"id":"A1142","pred":"tao:has_database_id","subj":"1142","obj":"MESH:C000657245"},{"id":"A1143","pred":"tao:has_database_id","subj":"1143","obj":"MESH:D016638"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":") and specific symptoms (loss of smell or taste and stroke) were described (91, 113–115). Epidemiological studies have reported that some patients infected with SARS‐CoV‐2 did report headaches (8%), nausea, or vomiting (1%). A more recent study investigating 214 COVID‐19 patients found that about 88% of critically ill patients displayed neurologic manifestations, including acute cerebrovascul"}